Chayadi E, Baes N, Kiropoulos L (2022) The effects of mindfulness-based interventions on symptoms of depression, anxiety, and cancer-related fatigue in oncology patients: A systematic review and meta-analysis. PLoS ONE 17(7):e0269519

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giaquinto AN et al (2022) Breast Cancer Statistics, 2022. CA Cancer J Clin 72(6):524–541

Article  PubMed  Google Scholar 

Mitchell AJ et al (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 12(2):160–174

Article  PubMed  Google Scholar 

Spiegel D, Giese-Davis J (2003) Depression and cancer: mechanisms and disease progression. Biol Psychiatry 54(3):269–282

Article  PubMed  Google Scholar 

Wang Y-H et al (2020) Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol Psychiatry 25(7):1487–1499

Article  PubMed  Google Scholar 

Wang X et al (2020) Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients. Mol Psychiatry 25(12):3186–3197

Article  PubMed  PubMed Central  Google Scholar 

Janelsins MC et al (2014) Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry (Abingdon, England) 26(1):102–113

Article  PubMed Central  Google Scholar 

Hassan M et al (2023) Cognitive functioning in women with breast cancer: psychometric properties of the Arabic version of the functional assessment of cancer therapy-cognitive function tool. Health Qual Life Outcomes 21(1):9

Article  PubMed  PubMed Central  Google Scholar 

Ando-Tanabe N et al (2014) Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls. Breast Cancer 21(4):453–462

Article  PubMed  Google Scholar 

DeSantis CE et al (2019) Breast cancer statistics, 2019. CA Cancer J Clin 69(6):438–451

Article  PubMed  Google Scholar 

(U.S.), N.C.I. (2015) Online Summary of Trends in US Cancer Control Measures Breast Cancer Treatment

Braybrooke J et al (2023) Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials. Lancet 401(10384):1277–1292

Article  Google Scholar 

Janelsins MC et al (2011) An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol 38(3):431–438

Article  PubMed  PubMed Central  Google Scholar 

Janelsins MC et al (2012) Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support Care Cancer 20(4):831–839

Article  PubMed  Google Scholar 

Sauter KA et al (2011) Doxorubicin and daunorubicin induce processing and release of interleukin-1beta through activation of the NLRP3 inflammasome. Cancer Biol Ther 11(12):1008–1016

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tangpong J et al (2006) Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity. Neurobiol Dis 23(1):127–139

Article  CAS  PubMed  Google Scholar 

Ibrahim EY et al (2021) Cognitive effects and depression associated with taxane-based chemotherapy in breast cancer survivors: a meta-analysis. Front Oncol 11:642382

Article  CAS  PubMed  PubMed Central  Google Scholar 

Verhoeff-Jahja R et al (2022) Symptoms of anxiety but not depression before start of taxane-based chemotherapy are associated with peripheral neuropathy: a multicenter study in women with breast cancer. Support Care Cancer 30(8):6947–6953

Article  PubMed  PubMed Central  Google Scholar 

Schwab L, Visovsky C (2022) Psychological distress and quality of life in breast cancer survivors with taxane-induced peripheral neuropathy: a scoping review. Front Oncol 12:1005083

Article  CAS  PubMed  Google Scholar 

Graeber MB, Streit WJ (1990) Microglia: immune network in the CNS. Brain Pathol 1(1):2–5

Article  CAS  PubMed  Google Scholar 

Keeney JTR et al (2018) Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”). Oncotarget 9(54):30324–30339

Article  PubMed  PubMed Central  Google Scholar 

Ren X et al (2019) The triangle of death of neurons: Oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment (“chemobrain”) involving TNF-alpha. Free Radic Biol Med 134:1–8

Ibrahim EY, Ehrlich BE (2020) Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings. Crit Rev Oncol Hematol 145:102831

Article  PubMed  Google Scholar 

Maier K et al (2007) Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation. Neurobiol Dis 25(3):514–525

Article  CAS  PubMed  Google Scholar 

Neigh GN et al (2009) Anxiety after cardiac arrest/cardiopulmonary resuscitation: exacerbated by stress and prevented by minocycline. Stroke 40(11):3601–3607

Article  PubMed  PubMed Central  Google Scholar 

Stirling DP et al (2004) Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci 24(9):2182–2190

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng S et al (2015) Minocycline reduces neuroinflammation but does not ameliorate neuron loss in a mouse model of neurodegeneration. Sci Rep 5(1):10535

Article  PubMed  PubMed Central  Google Scholar 

Zhang L et al (2018) Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: Association with pro-inflammatory cytokine levels. Prog Neuropsychopharmacol Biol Psychiatry 85:69–76

Article  CAS  PubMed  Google Scholar 

Hailer NP (2008) Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog Neurobiol 84(3):211–233

Article  CAS  PubMed  Google Scholar 

Popovic N et al (2002) Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann Neurol 51(2):215–223

Article  CAS  PubMed  Google Scholar 

Yrjänheikki J et al (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95(26):15769–15774

Article  PubMed  PubMed Central  Google Scholar 

Won SJ et al (2012) Prevention of hypoglycemia-induced neuronal death by minocycline. J Neuroinflammation 9:225

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dean OM et al (2012) Minocycline. CNS Drugs 26(5):391–401

Article  CAS  PubMed  Google Scholar 

Himmel LE et al (2016) Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer. Exp Toxicol Pathol 68(9):505–515

Article  CAS  PubMed  PubMed Central